Literature DB >> 22873725

Doxorubicin-induced in vivo nephrotoxicity involves oxidative stress-mediated multiple pro- and anti-apoptotic signaling pathways.

Tejas S Lahoti1, Darshan Patel, Venkatesh Thekkemadom, Robert Beckett, Sidhartha D Ray.   

Abstract

Doxorubicin (DOX), a prominent anticancer agent has enjoyed considerable popularity in the last few decades because of its usefulness in the management of various forms of cancers, but its organotoxic potential (cardio-, hepatoand nephrotoxicity) has constrained on its clinical use. This study investigated whether DOX has the ability to cause nephrotoxicity in vivo and if so, whether it is linked to oxidative stress (OS). Another important goal was to describe whether expression of pro- and anti-apoptotic genes in kidneys was driven by OS. In order to explore DOX's nephrotoxic potential, male rats (Sprague Dawley; 500-520g; fed ad libitum) were administered i.p. with a single dose of DOX (12 mg/kg) on day one and sacrificed seven days later (day 8). Changes in serum chemistries (i.e., serum urea nitrogen, SUN, and creatinine) were determined immediately upon sacrifice, whereas kidney tissues were subjected to several sensitive biomarkers for OS, such as, lipid peroxidation, Superoxide dismutase (SOD) activity and chromatin fragmentation. The most important goal was to evaluate the select expression of Apaf-1, Caspase-3, Bad, Bax, Bcl-2, Bcl-xL, p53 and Mdm2 genes in order to understand the underlying link between extrinsic and intrinsic pathways of cell death. Data revealed that DOX-exposed animals showed significant nephrotoxicity as reflected in increased SUN (5.6-fold) and creatinine (2.65 fold) levels with considerably decreased body weight. Increases in kidney injury markers reflected parallel elevations in lipid peroxidation (1.7-fold) and genomic DNA fragmentation (2.9 fold) coupled with a proportionate reduction in total SOD activity suggesting DOX-assaulted kidneys encountered massive OS. Western blot showed very striking changes: i) substantial increases in the expression of pro-apoptotic APAF-1, Caspase-3, Bax and Bad proteins; ii) Reduction in the expression of anti-apoptotic Bcl-2 and Bcl-xL genes; iii) considerable increase in the expression of p53 and suppression of its regulator Mdm2. Serum chemistry and tissue biochemistry mirrored histopathology. In conclusion, this study for the first time may have shown a close link between mitochondrial perturbations and cell death regulating genes during DOXinduced nephrotoxicity, and described DOX's potential to inflict kidney injury in addition to other organs during chemotherapy in clinical setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873725     DOI: 10.2174/156720212803530636

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  17 in total

Review 1.  WISP1: Clinical insights for a proliferative and restorative member of the CCN family.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014       Impact factor: 1.990

2.  miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells.

Authors:  A A Takwi; Y-M Wang; J Wu; M Michaelis; J Cinatl; T Chen
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

3.  β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+/AMPK/NF-kB in mice.

Authors:  Davoud Sanajou; Saeed Nazari Soltan Ahmad; Vahid Hosseini; Ashkan Kalantary-Charvadeh; Yasser Marandi; Leila Roshangar; Saman Bahrambeigi; Mehran Mesgari-Abbasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-23       Impact factor: 3.195

4.  Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice.

Authors:  Lamiaa A Ahmed; Nagwa I Shehata; Noha F Abdelkader; Mahmoud M Khattab
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

5.  Huaier Cream Protects against Adriamycin-Induced Nephropathy by Restoring Mitochondrial Function via PGC-1α Upregulation.

Authors:  Ruochen Che; Chunhua Zhu; Guixia Ding; Min Zhao; Mi Bai; Zhanjun Jia; Aihua Zhang; Songming Huang
Journal:  PPAR Res       Date:  2015-03-11       Impact factor: 4.964

6.  The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.

Authors:  Beshay N Zordoky; M Judith Radin; Lois Heller; Anthony Tobias; Ilze Matise; Fred S Apple; Sylvia A McCune; Leslie C Sharkey
Journal:  Cardiooncology       Date:  2016-03-15

7.  Doxorubicin induces dysregulation of AMPA receptor and impairs hippocampal synaptic plasticity leading to learning and memory deficits.

Authors:  Ahmad H Alhowail; Priyanka D Pinky; Matthew Eggert; Jenna Bloemer; Lauren N Woodie; Manal A Buabeid; Subhrajit Bhattacharya; Shanese L Jasper; Dwipayan Bhattacharya; Muralikrishnan Dhanasekaran; Martha Escobar; Robert D Arnold; Vishnu Suppiramaniam
Journal:  Heliyon       Date:  2021-07-01

8.  ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment: possible implications for cancer chemotherapy.

Authors:  Leonardo M Fonseca; Adriana B Alvarez; Rachel C Rodrigues; Diego H F Santos; Anibal G Lopes; Marcia A M Capella
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

9.  A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy.

Authors:  Thu Le Trinh; Guizhi Zhu; Xilin Xiao; William Puszyk; Kwame Sefah; Qunfeng Wu; Weihong Tan; Chen Liu
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

10.  Acute liver injury induced by low dose dimethylnitrosamine alters mediators of hepatic vascular flow.

Authors:  G Jayakumar Amirtharaj; Kavitha R Thangaraj; Archana Kini; Raghupathy V; Ashish Goel; Eapen C E; Aparna Venkatraman; Anna B Pulimood; Balasubramanian K A; Anup Ramachandran
Journal:  Toxicol Rep       Date:  2014-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.